cas 24867-26-3|| where to buy 6-(piperidin-1-yl)pyrimidine-2,4-diamine

Nom du produit:6-(piperidin-1-yl)pyrimidine-2,4-diamine

IUPAC Name:6-(piperidin-1-yl)pyrimidine-2,4-diamine

Unité d'emballage	Stock disponible	Prix($)
CM166442-250mg	in stock	ţţ
CM166442-1g	in stock	Ĝǭţ
CM166442-5g	in stock	ŁƩŽ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 24867-26-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:24867-26-3; Formule moléculaire:C9H15N5; Point de fusion:-; Code SMILES:NC1=NC(N)=NC(=C1)N1CCCCC1; Densité:

: Numéro de catalogue:CM166442; Poids moléculaire:193.25; Point d'ébullition:495.6°C at 760 mmHg; N° Mdl:MFCD04973589; Stockage:Keep in dark place, store at 2-8°C.

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.